
Share
Published 12:43 17 Dec 2018 GMT

221 women were affected by the CervicalCheck controversy which saw false negative results delivered to patients under the national screening programme. Among them was Vicky Phelan who settled a High Court case against the HSE and one of the laboratories used, Clinical Pathology Laboratories (CPL), earlier this year. The Irish Times reported that 43-year-old Vicky "initially paid out of her own pocket for Pembrolizumab, which costs €8,500 per infusion every three weeks."This is the best Christmas present I could get this year. Thank you to @alankellylabour and @ClaireByrneLive for working with me on this. Thank you @SimonHarrisTD and Prof Barry for making this happen. https://t.co/UQHlIrHVso
— Vicky Phelan (@PhelanVicky) December 15, 2018
Pembrolizumab significantly reduced the size of her tumours and earlier this month the mum of two said:
"I am evidence that this drug works."Mr Harris told RTÉ:
"I’ve spoken to Michael this morning and they hope to be in a position to make this drug available to all women with cervical cancer for whom it’s clinically suitable very shortly."Vicky is due to speak on the Claire Byrne show at 10:35 pm on RTÉ One tonight.
Explore more on these topics: